Infinium Pharmachem Limited (NSE:INFINIUM)

Market Cap	3.84B
Revenue (ttm)	1.56B
Net Income (ttm)	81.45M
Shares Out	15.58M
EPS (ttm)	5.60
PE Ratio	43.99
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Average Volume	2,575
Open	253.00
Previous Close	247.75
Day's Range	252.00 - 253.00
52-Week Range	213.90 - 350.00
Beta	0.18
RSI	49.59
Earnings Date	Oct 27, 2025

About Infinium Pharmachem

Infinium Pharmachem Limited engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally. The company provides iodine based molecules/APIs/iodination reaction based bulk drugs. It also offers potassium iodide and iodate, sodium iodide, iodine, povidone iodine, pralidoxime iodide, thymol iodide, and iodoform products. In addition, the company provides contract research and manufacturing services to pharmaceutical and biotech companies for iodine based APIs and inte...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2003
• Employees: 144
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INFINIUM

Financial Performance

In 2024, Infinium Pharmachem's revenue was 1.56 billion, an increase of 14.78% compared to the previous year's 1.36 billion. Earnings were 81.45 million, a decrease of -27.93%.